The treatment is a solution for female sexual dysfunction (FSD).
Investor deep dive
Callitas Health capitalizes on CannaStrips, OTC goods while swinging for the fence with blockbuster drugs
M Pharma's Gary Thompson 'excited' to receive US Extrinsa trademark
Quick facts: Callitas Health Inc.
Market Cap: $3.62 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc. named herein, including the promotion by the Company of Callitas Health Inc. in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE